Back
Company

HerelleX joins LAB+ at Institut Pasteur de Montevideo

It is Uruguay's first company builder specializing in life sciences.

Retrato de Agustín Seijo
Agustín SeijoCEO
Grupo de siete personas, tres de pie y cuatro sentadas, posando juntas en un espacio interior

HerelleX is joining LAB+ Company Builder, Uruguay’s first company builder specializing in life sciences, an initiative led by Institut Pasteur de Montevideo.

Founders of the startups in the new LAB+ cohort.
Founders of the startups in the new LAB+ cohort.

A regional ecosystem

This is more than joining a program: we are becoming part of a regional innovation ecosystem with global reach, one that connects scientific knowledge, business expertise and capital.

What we value most is the opportunity to build networks with scientists, academic institutions, industry leaders and investors who share a common purpose: transforming high-quality science into solutions with real-world impact.

A new chapter

Thank you to the LAB+ team for their trust. We are excited to begin this chapter alongside the other startups in the new cohort.

See all news

Recommended reading

Get involved

Bring FluoTB to where it's needed.

The potential market is ~200,000 tests a year in Argentina and over 30 million a year across high-incidence countries — a global TB-diagnostics market projected to grow from USD 2.28B in 2024 to USD 3.18B by 2030. If accessible diagnosis is your mission too, let's talk.

Request a PilotRead the science

Simplified view

One sample. One test, adjusted to routine lab workflows.

A respiratory sample is processed with standard lab methods, incubated with our reagents, then fixed for safe fluorescence reading — even up to 10 days later.

01.

Decontamination

Competing flora is cleared.

02.

Infect and express

Sample meets phage reagents.

03.

Fixation

Fixed — safe to handle and store.